Travere Therapeutics, Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Feb 2011 | — | $-60.3K | — |
| Mar 2011 | — | $0 | $0 |
| Nov 2011 | — | $-61.8K | — |
| Dec 2011 | — | $-536.3K | $10.1K |
| Feb 2012 | — | $-63.1K | — |
| Mar 2012 | — | — | $1.3K |
| May 2012 | — | $-63.6K | — |
| Jun 2012 | — | — | $31.4K |
| Aug 2012 | — | $-64.1K | — |
| Sep 2012 | — | — | $2.2K |
| Nov 2012 | — | $-64.8K | — |
| Dec 2012 | — | $-3.4M | $11.0K |
| Mar 2013 | — | $-3.6M | $2.5M |
| Jun 2013 | — | $-8.5M | $286.5K |
| Sep 2013 | — | $-9.6M | $13.4M |
| Dec 2013 | — | $-19.7M | $6.0M |
| Mar 2014 | — | $-35.4M | $3.7M |
| Jun 2014 | $91 | $1.1M | $39.9M |
| Sep 2014 | $91.0M | $-10.2M | $25.9M |
| Dec 2014 | — | $-37.3M | $18.2M |
| Mar 2015 | $91.0M | $168.6M | $120.2M |
| Jun 2015 | $91.0M | $150.8M | $127.7M |
| Sep 2015 | $46.0M | $291.0M | $140.6M |
| Dec 2015 | — | $300.0M | $37.8M |
| Mar 2016 | — | $319.2M | $23.3M |
| Jun 2016 | — | $314.4M | $21.2M |
| Sep 2016 | — | $307.6M | $23.9M |
| Dec 2016 | — | $307.8M | $41.0M |
| Mar 2017 | — | $300.9M | $41.9M |
| Jun 2017 | — | $295.8M | $89.3M |
| Sep 2017 | — | $304.5M | $99.0M |
| Dec 2017 | — | $293.1M | $99.4M |
| Mar 2018 | — | $299.5M | $61.1M |
| Jun 2018 | — | $288.0M | $89.3M |
| Sep 2018 | $22.6M | $319.1M | $154.8M |
| Dec 2018 | — | $318.3M | $102.9M |
| Mar 2019 | — | $285.7M | $69.8M |
| Jun 2019 | — | $277.1M | $75.7M |
| Sep 2019 | — | $246.0M | $65.2M |
| Dec 2019 | — | $221.2M | $62.4M |
| Mar 2020 | — | $225.7M | $67.0M |
| Jun 2020 | — | $318.6M | $237.2M |
| Sep 2020 | — | $301.4M | $200.5M |
| Dec 2020 | — | $211.2M | $84.8M |
| Mar 2021 | — | $362.7M | $148.2M |
| Jun 2021 | — | $332.3M | $83.3M |
| Sep 2021 | — | $307.4M | $150.3M |
| Dec 2021 | — | $302.1M | $165.8M |
| Mar 2022 | — | $208.1M | $256.6M |
| Jun 2022 | — | $156.7M | $179.8M |
| Sep 2022 | — | $100.7M | $151.3M |
| Dec 2022 | — | $42.9M | $61.7M |
| Mar 2023 | — | $189.1M | $161.4M |
| Jun 2023 | — | $116.5M | $70.9M |
| Sep 2023 | — | $279.8M | $144.2M |
| Dec 2023 | — | $200.8M | $58.2M |
| Mar 2024 | — | $74.1M | $43.3M |
| Jun 2024 | — | $15.1M | $32.3M |
| Sep 2024 | — | $-30.5M | $36.4M |
| Dec 2024 | — | $59.1M | $58.5M |
| Mar 2025 | — | $32.8M | $61.9M |
| Jun 2025 | — | $32.7M | $75.2M |
| Sep 2025 | — | $73.6M | $110.9M |
| Dec 2025 | — | $114.8M | $93.0M |
| Mar 2026 | — | $98.7M | $78.4M |
| Jun 2026 | — | $24.5M | $117.7M |